Stocks to sell

When it comes to stocks, I tend to be a glass-half-full kind of person, which is why I don’t often write about stocks to sell.  Alas, you can run, but you can’t hide. So I’ve been asked to come up with 10 names I feel investors ought to jettison before they crash and burn.  What

No matter how the novel coronavirus pandemic pans out from here, more than likely, history will regard Novavax (NASDAQ:NVAX) stock as a Cinderella tale. Source: Ascannio/Shutterstock.com Just a year before Novavax earned a $1.6 billion award from the Trump administration’s Operation Warp Speed initiative, the company was on the verge of collapse. Then, seemingly out

AMC (NYSE:AMC) announced the appointment of CEO Adam Aron to the additional position of Chairman of the Board on July 21. Before you run out to buy AMC stock on the news, you might want to do a stress test on America’s largest movie theater chain.  Source: Sundry Photography / Shutterstock.com You might not like

Inarguably, one of the current century’s biggest investment narratives has been the rise of China stocks. Once a mess of an economy suffering from an identity crisis, the Asian juggernaut embraced Western-style capitalism — at least in its business dealings. Quickly, the so-called Chinese miracle occurred, catapulting the nation to an economic powerhouse second only

Krispy Kreme (NASDAQ:DNUT) just went public again for the second time, when its private equity owner JAB Holding sold less than 20% of its shares to the public at $17. Unfortunately, most of the money will just be used to reduce the company’s debt. DNUT stock will is still trading at a high Enterprise Value

Prior to the U.S. Postal Service making its announcement regarding which company will replace its aging fleet of mail carriers, Workhorse (NASDAQ:WKHS) showed great promise. As the only fully electric-based proposal, the company aligned perfectly with the zero-emissions sentiment that was gradually building bipartisan support. Thus, WKHS stock appeared a no-brainer. Source: Shutterstock As it

Based on my financial analysis, I would not touch Bionano Genomics (NASDAQ:BNGO) right now. I would run fast and far away from BNGO stock. But why? There are several reasons, and they all have to do with fundamentals. Source: Natali_ Mis/ShutterStock.com While the company has a positive catalyst here and there, its revenue and subsequent

In all my articles about stocks on InvestorPlace, I save my investment thesis for the end. But for GameStop (NYSE:GME), let me be upfront: I do not like the stock, its fundamentals or certainly its lofty price. Source: rblfmr / Shutterstock.com There are many good stocks listed on the U.S. stock exchanges, and many of them

In the rosiest of scenarios for Ocugen (NASDAQ:OCGN) stock, the Covaxin vaccine for the novel coronavirus will be approved by the FDA only around the second quarter of 2023. And the company appears to be dragging its feet on getting the process started. Source: shutterstock.com/PhotobyTawat Meanwhile, information I recently uncovered suggests that Canada will probably

Many may be waiting for the other shoe to drop with Gamestop (NYSE:GME) stock. But not even market-wide jitters about the Delta variant could knock down the most popular “meme stock.” In fact, on the day the Dow slumped over concerns, GME stock ticked higher rather than lower. Source: Emil O / Shutterstock.com Will this

Health insurance company Clover Health (NASDAQ:CLOV) is on a mission to lower costs for Medicare patients. So far, it is spending more money than it brings in. Additionally, activist short-seller Hindenburg Research released a scathing report that criticizes its business model and the quality of its software. As a result, CLOV stock is incredibly volatile

AMC Entertainment (NYSE:AMC) stock been on a rollercoaster ride so far this year. The r/WallStreetBets community turned the investment world upside down by joining forces to bid up AMC stock, boosting the price by nearly 3,000% at one point in the year via short squeezes. These wild swings in price have in fact become a virtual showdown

A number of new positive catalysts have been added to the mix for GameStop (NYSE:GME). However, despite the potential for a boost, GME stock remains extremely overvalued. Source: Northfoto / Shutterstock.com The biggest factor in GameStop’s future is Netflix’s (NASDAQ:NFLX) reported entry into the video game sector. Many investors viewed this as a negative development

In any other circumstance, Opendoor Technologies (NASDAQ:OPEN) stock may have been a no-brainer investment. Source: PREMIO STOCK/Shutterstock.com As you probably know, owning real estate is the epitome of the American Dream — but the paperwork to seal the deal is a veritable nightmare. Opendoor’s digitalization of the buying and selling process is the answer we’ve

Clover Health Investments (NASDAQ:CLOV) recently reported Q1 revenue and earnings on May 17. The numbers weren’t particularly thrilling for CLOV stockholders. Source: Valeri Potapova / Shutterstock.com On May 13 I wrote that the Medicare Advantage insurer would likely report 21% higher revenue year-over-year. But I also cautioned that CLOV stock was unlikely to move much

Fisker (NYSE:FSR) stock has made big news without the company having delivered a single car to date. Of course, a lot of EV companies are making news this year. Source: Eric Broder Van Dyke / Shutterstock.com With Tesla (NASDAQ:TSLA) leading the industry, there are lots of other EV makers who are trying to take a

Early investors of Ocugen (NASDAQ:OCGN) stock have seen a substantial amount of return for their investment. Source: Shutterstock As early as December of last year OCGN stock has been at the $0.30 level. The stock price moved exponentially at the news that the company had signed an agreement with Bharat Biotech. The stock reached a

Small biotech companies such as Denmark’s Orphazyme (NASDAQ:ORPH) usually have one major product, which pushes them into the spotlight. For ORPH stock, that one product is Arimoclomol. Source: Iryna Imago / Shutterstock.com Arimoclomol is a drug that could treat the rare progressive genetic disorder called Niemann-Pick Disease Type C (NPC). Investors looking for a breakthrough

Compared to the gigantic valuation of Churchill Capital Corp IV (NYSE:CCIV) stock, the performance of Lucid Motors — with whom Churchill is expected to merge next week — remains subpar. Source: gg5795 / Shutterstock.com Meanwhile, CCIV stock has been badly hurt by the retreat of meme stocks in the last month, and I expect that trend

The Airbnb (NASDAQ:ABNB) story is well recognized among investors today as the company that invented a travel and lodging category that did not formally exist before. ABNB stock has had a storied time since the company went public. Source: AlesiaKan / Shutterstock.com Airbnb is a so-called two-sided online marketplace (meaning both hosts and guests are